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The TrcRS two-component system of Mycobacterium tuberculosis is comprised of the TrcS histidine kinase
and the TrcR response regulator, which is homologous to the OmpR class of DNA binding response regulators.
Reverse transcription-PCRs with total RNA showed that the trcR and trcS two-component system genes are
transcribed in broth-grown M. tuberculosis. Analysis of the trcR and trcS genes using various SCOTS (selective
capture of transcribed sequences) probes also confirmed that these genes are expressed in broth-grown
cultures and after 18 h of M. tuberculosis growth in cultured human primary macrophages. To determine if the
TrcR response regulator is autoregulated, a trcR-lacZ fusion plasmid and a TrcR expression plasmid were
cotransformed into Escherichia coli. Upon induction of the TrcR protein, there was a >500-fold increase in
␤-galactosidase activity from the trcR-lacZ fusion, indicating that TrcR is involved in transcriptional autoactivation. Gel mobility shift assays with the trcR promoter and TrcR established that the response regulator was
autoregulating via direct binding. By use of a delimiting series of overlapping trcR PCR fragments in gel
mobility shift assays with TrcR, an AT-rich region of the trcR promoter was shown to be essential for TrcR
binding. Additionally, this AT-rich sequence was protected by TrcR in DNase I protection assays. To further
analyze the role of the AT-rich region in TrcR autoregulation, the trcR promoter was mutated and analyzed in
lacZ transcriptional fusions in the presence of TrcR. Alteration of the AT-rich sequence in the trcR promoter
resulted in the loss of trcR transcriptional activation in the presence of TrcR. This report indicates that the M.
tuberculosis TrcR response regulator activates its own expression by interacting with the AT-rich sequence of
the trcR promoter.

Mycobacterium tuberculosis persists as the leading cause of
death from an infectious agent, accounting for nearly 2.4 million deaths annually (20). With the proliferation of multidrugresistant strains and the association with AIDS, this global
impact of tuberculosis will inevitably continue. As an intracellular pathogen, M. tuberculosis must be able to survive and
adapt to various environmental conditions encountered during
host aerosolization, macrophage phagocytosis, latency, and reactivation. In response to changing environmental conditions,
bacteria commonly utilize two-component sensor histidine kinase/response regulator networks to modulate appropriate
gene expression (for a review, see reference 30). Since it is now
widely accepted that pathogenic bacteria use two-component
regulatory systems to regulate expression of virulence factors
(5, 16, 17), it is believed that M. tuberculosis will also utilize this
mechanism to help fulfill its pathogenic lifestyle.
The complete sequence of the M. tuberculosis genome reveals the presence of 11 paired two-component regulatory systems, two unlinked, orphan histidine kinase genes, and six
unlinked, orphan response regulator genes (3). To date, five
systems, MtrA/MtrB (33, 35), TrcR/TrcS (9), SenX3/RegX3
(11), DevR/DevS (Rv3133c/Rv3132c) (4, 28), and PhoP/PhoR
(23), have been partially characterized. The mtrA response

regulator was deemed essential due to the inability to generate
an M. tuberculosis mtrA mutant without an extrachromosomal
copy of the mtrA gene (35). Recently, the Rv3133c/Rv3132c
two-component system genes were shown to be induced under
hypoxic conditions, and the Rv3133c response regulator was
shown to be involved in the regulation of ␣-crystallin (acr)
expression (28). In another recent report, an M. tuberculosis
phoP mutant was impaired in its ability to multiply in mouse
bone marrow-derived macrophages and was attenuated in
mice (23).
Phosphorylation signal transduction between a sensor/histidine kinase and its cognate DNA binding response regulator
triggers the regulation of genes involved in a particular adaptive response (30). It has previously been shown that the M.
tuberculosis TrcR/TrcS two-component system communicates
via cognate phosphorylation and thus constitutes a functional
signal transduction circuit (9). However, the genes regulated
by the TrcRS proteins have not yet been identified.
TrcR belongs to the response regulator protein subfamily
that also includes OmpR, PhoB, PhoP, and VirG (22, 34).
Response regulators from other bacteria classified within this
subgroup regulate 70 promoters and contain a C-terminal
helix-turn-helix motif responsible for DNA binding (22). While
many two-component systems have been implicated in bacterial pathogenesis and in the regulation of multiple virulence
factors, these same systems are also often involved in autoregulation. For example, while the PhoPQ system of Salmonella
enterica serovar Typhimurium is important in intramacrophage

* Corresponding author. Mailing address: Washington University,
Dept. of Biology, Campus Box 1137, St. Louis, MO 63130. Phone:
(314) 935-7323. Fax: (314) 935-4432. E-mail: haydel@biology.wustl
.edu.
2192

MYCOBACTERIUM TUBERCULOSIS TrcR CHARACTERIZATION

VOL. 184, 2002

2193

TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid

Description

Strains
M. tuberculosis H37Rv
M. tuberculosis TB233
E. coli JM109
Plasmids
pJEM15
pACYC184
pSEH100
pSH93
pGEM-T
pYH4
pSH33
pSH234
pSH237
pSH266
pSH337
a

Source or reference

Virulent laboratory strain

ATCCa

Virulent clinical isolate
e14⫺ (McrA⫺) recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 ⌬(lac-proAB)

Laboratory collection
Stratagene

E. coli-mycobacterial shuttle vector, Kmr
E. coli low-copy-number p15A origin cloning vector, Cmr Tcr
pJEM15 with p15A origin from pACYC184
pSEH100 with trcR promoter cloned upstream of the lacZ gene
E. coli cloning vector, Apr
pZErO/Kmr plasmid containing trcR and 1,039 bp of trcS
His6-tagged recombinant TrcR expression plasmid
pGEM-T with 210 bp of the trcR promoter/intergenic region
pGEM-T with 195 bp of the trcR promoter and coding region
pSH93 with the 36-bp mutated trcR promoter
pGEM-T with 1,311 bp of clpC (Rv3596c)

31
2
This study
This study
Promega
9
9
This study
This study
This study
This study

ATCC, American Type Culture Collection.

survival (6) and is predicted to control the expression of up to
40 proteins (7, 19), the phoPQ operon has also been identified
as a PhoP-activated locus (29). The BvgA response regulator
from Bordetella pertussis controls the expression of many virulence-associated genes, such as pertussis toxin and filamentous
hemagglutinin (26), and also regulates the synthesis of the
bvgAS operon (27).
Here, we present data regarding the expression of the trcR
and trcS genes in broth-grown cultures and in macrophages as
well as the expression of the TrcR protein in M. tuberculosis
cultures. Transcriptional analysis of the trcR promoter in the
presence of TrcR indicates that the TrcR response regulator
regulates its own expression. Biochemical characterization of
TrcR DNA binding activity reveals that the response regulator
binds to the trcR promoter by interacting with an AT-rich
region of DNA, and this interaction is essential for TrcR autoregulation.
MATERIALS AND METHODS
Media and bacterial growth conditions. Escherichia coli cultures were grown in
Luria-Bertani (LB) broth or on LB agar plates at 37°C. M. tuberculosis cultures
were grown under standard conditions in Middlebrook 7H9 liquid medium
(Difco Laboratories, Detroit, Mich.) with or without 0.2% glycerol and supplemented with Middlebrook ADC enrichment (Becton Dickinson, Franklin Lakes,
N.J.) and 0.05% Tween 80 at 37°C. The following concentrations of antibiotics or
inducing supplement were added when appropriate: ampicillin (Ap), 100 g/ml;
kanamycin (Km), 50 g/ml; isopropyl-␤-D-thiogalactopyranoside (IPTG), 0.1 or
1.0 mM.
Bacterial strains and plasmids. Bacterial strains and plasmids used in this
study are listed in Table 1. E. coli strain JM109 was used as a host for all plasmid
constructions and ␤-galactosidase analyses. M. tuberculosis strain H37Rv (3) and
strain TB233, a recent clinical isolate, were used in this study.
The pJEM15 E. coli-mycobacterial shuttle plasmid (31) was used for M. tuberculosis promoter-lacZ fusions after it was altered to reduce the plasmid copy
number by exchanging the E. coli pBR322 origin of replication and a portion of
the mycobacterial origin of replication for the p15A origin of replication from
pACYC184 (2). The resulting plasmid, pSEH100, had 10 to 12 copies per cell (2)
and was used to generate pSH93, which consists of a 300-bp fragment containing
the trcR promoter and 60 bp of the trcR coding region cloned upstream of the
lacZ gene in pSEH100. pSH93 is compatible with the TrcR expression plasmid,
pSH33 (9), which has a ColE1 origin of replication. The pSH227 plasmid was
constructed by PCR amplification of the full-length trcR and trcS genes from M.
tuberculosis H37Rv with primers SH36 (5⬘-AACGCGGCTACGGCTGGGAC-

3⬘) and SH22 (5⬘-CAATATCTCGATAAGGCAGG-3⬘) and by subsequent cloning into the pGEM-T vector (Promega Corporation, Madison, Wis.). pSH337
contains a portion of the M. tuberculosis clpC (Rv3596c) gene amplified by using
primers clpCF (5⬘-ACATTCCGTTTACCCCCCG-3⬘) and clpCR (5⬘-GCTCTT
CTTCCATCCGCAACAG-3⬘) and cloned into pGEM-T (Promega Corporation).
RNA isolation. Total RNA was isolated from M. tuberculosis (H37Rv and
TB233) cultures grown as described above with glycerol by using the FastRNA
Blue Kit (BIO 101, Inc., Vista, Calif.) according to the manufacturer’s instructions. Extracted RNA was resuspended in diethylpyrocarbonate-treated water
and treated with DNase (Ambion, Inc., Austin, Tex.). DNA-free RNA samples
were stored at ⫺70°C in diethylpyrocarbonate-treated water and RNase inhibitor
(Ambion, Inc.).
RT-PCR. Reverse transcription (RT)-PCR was performed using ReadyTo-Go RT-PCR beads as described in the manufacturer’s protocol (Amersham
Pharmacia Biotech, Piscataway, N.J.). Each bead contains recombinant Moloney
murine leukemia virus reverse transcriptase for cDNA synthesis, DNA polymerase for amplification, RNase inhibitor, buffer, and deoxynucleoside triphosphates
in a glass matrix. One to two micrograms of DNA-free total RNA was added to
the RT-PCR beads, reverse transcribed at 42°C with the appropriate reverse trcR
or trcS primer, and PCR amplified for 30 cycles at an annealing temperature of
55°C. RNA samples were concurrently analyzed in PCR mixtures without reverse
transcriptase to verify the absence of contaminating genomic DNA. PCR mixtures were analyzed on a 2% agarose gel. Primers used for trcR were SH29
(5⬘-ACGACGATGTCGGGGTACACG-3⬘) and SH20 (5⬘-CCCCGTCGAGCG
TAAGGTC-3⬘); for trcS, they were SH42 (5⬘-GACCTACCGCCCACCACCG
A-3⬘) and SH21 (5⬘-CAATATCTCGATAAGGCAGG-3⬘); for the trcR and trcS
intergenic region, they were SH23 (5⬘-CCCCGACGAGCACTGAGCCG-3⬘)
and SH16 (5⬘-GCGTGCAGGGATTCGACTAGC-3⬘).
SCOTS analysis. The pYH4 plasmid (9), containing the trcR gene, 1,039 bp of
the trcS gene, and upstream flanking DNA, and the pSH337 plasmid, containing
a portion of the M. tuberculosis clpC (Rv3596c) gene, were analyzed by using
previously described selective capture of transcribed sequences (SCOTS) cDNA
probes (8). The clpC gene was expressed during mycobacterial growth in broth
and in macrophages and was used as a positive control in all hybridization
experiments. Plasmid DNA was digested with appropriate restriction enzymes,
separated by agarose gel electrophoresis, and transferred onto GeneScreen Plus
membranes (NEN Life Science, Boston, Mass.). Transferred DNAs were then
hybridized with the various SCOTS cDNA digoxigenin (DIG)-labeled probes
and detected by anti-DIG-alkaline phosphatase and the CDP-Star chemiluminescent alkaline phosphatase substrate as described by the manufacturer (Roche,
Indianapolis, Ind.). Membranes were exposed to X-ray film at room temperature
for 15 to 60 min.
The M. tuberculosis SCOTS cDNA probes were developed from mRNAs
specifically expressed during growth in Middlebrook 7H9 broth and during intracellular growth within human macrophages for 18, 48, or 110 h (8). Briefly, for
the generation of SCOTS cDNA probes, total RNA was isolated from M. tuber-
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culosis cultures and converted to cDNA by RT. Terminal linker sequences were
added to the cDNA mixtures, and the cDNA was captured by hybridization with
biotinylated H37Rv chromosomal DNA that had been prehybridized with rrnA
DNA. The cDNA-chromosomal DNA hybrids were then separated from nonhybridized cDNAs by reacting with streptavidin-coated magnetic beads. After
elution from chromosomal DNA, the cDNA molecules were amplified by PCR.
Three rounds of selective capture of cDNAs (SCOTS) were performed before
preparing DIG-labeled probes from each cDNA mixture. DIG-labeled SCOTS
probes were generated by PCR or random-primed labeling with DIG-dUTP as
described by the manufacturer (Roche).
Mycobacterial protein extracts. M. tuberculosis H37Rv cultures were grown as
described above without glycerol and harvested by centrifugation at 4°C. Cells
were washed three times in cold phosphate-buffered saline (PBS) and resuspended in cold PBS containing 1 mM phenylmethylsulfonyl fluoride. The cell
suspension was transferred to a 2-ml Sarstedt screw-cap tube containing 0.6 ml
of 0.1-mm-diameter zirconia/silica beads (Biospec Products, Bartlesville, Okla.)
and was subjected to three 1-min pulses in a Mini-BeadBeater (Biospec Products) with at least 1-min rests on ice. Lysed cells were centrifuged for 10 min at
13,000 ⫻ g, and the cell supernatant containing cell-free protein extract was
collected. Protein concentrations were determined by using the Bio-Rad Protein
Assay kit (Bio-Rad Laboratories, Hercules, Calif.).
TrcR antibody generation and immunoblot analysis. Recombinant TrcR protein was produced in E. coli and purified as previously described (9). Purified
TrcR protein (⬃100 g) was emulsified in Freund’s incomplete adjuvant and
used to immunize two New Zealand White rabbits by subcutaneous injection.
Rabbits were given booster injections of TrcR antigen at 4-week intervals, and
antisera were collected after at least two booster injections.
M. tuberculosis protein extracts (20 g) were mixed with 0.05% sodium dodecyl
sulfate (final concentration) and native polyacrylamide gel electrophoresis
(PAGE) sample buffer, separated by native 10% PAGE, and electrotransferred
onto Protran nitrocellulose membranes (Schleicher & Schuell Inc., Keene,
N.H.). For control reactions in E. coli, the pQE40 vector was induced with 1 mM
IPTG to express His-tagged dihydrofolate reductase, and E. coli protein extracts
were processed as described in the manufacturer’s protocol (QIAexpressionist;
Qiagen, Inc., Valencia, Calif.). Membranes were blocked with 2.5% milk proteins
in PBS containing Tween 20 (0.05%), incubated with anti-TrcR rabbit polyclonal
antiserum, and developed with a horseradish peroxidase-labeled goat anti-rabbit
antiserum (Bio-Rad Laboratories or Sigma Chemical Co., St. Louis, Mo.) and
SuperSignal West Pico chemiluminescent substrate (Pierce, Rockford, Ill.).
Assay of ␤-galactosidase activity. TrcR autoregulatory experiments were performed in E. coli with a trcR promoter-lacZ transcriptional fusion and recombinant His6-tagged TrcR produced from the expression plasmid pSH33 (Apr) (9).
The trcR promoter-lacZ fusion plasmid, pSH93, and pSH33 were transformed
into E. coli JM109 and selected on LB/Ap/Km plates. Overnight cultures were
grown and diluted in fresh LB medium. Fresh cultures were grown to optical
densities at 600 nm of between 0.3 and 0.5 and were then induced with 0.1 mM
IPTG for 60 min. ␤-Galactosidase measurements were performed as previously
described and expressed as Miller units (18).
Protein purification and treatment of TrcR with acetyl phosphate. The TrcR
and TrcRN-term (N-terminal portion of TrcR) proteins were expressed and purified by nickel-nitrilotriacetic acid agarose columns as previously described (9).
In vitro phosphorylation of TrcR by acetyl phosphate was performed as described by McCleary (15). Briefly, TrcR was treated with 50 mM acetyl phosphate in phosphorylation buffer containing 50 mM Tris-HCl (pH 8.0), 10 mM
MgCl2, and 3 mM dithiothreitol (DTT) for 75 min at 37°C. Following phosphorylation with acetyl phosphate, TrcR was added to gel mobility shift assay reaction
mixtures (described below).
Gel mobility shift assays. Promoter DNA probes for gel mobility shift assays
were amplified by PCR from M. tuberculosis and 3⬘ end labeled with DIG as
described by the DIG Gel Shift Kit manufacturer (Roche). The primers used for
PCR amplification were synthesized by IDT, Inc. (Coralville, Iowa) or Oligos,
Etc. (Bethel, Maine). The trcR fragments, PCR primer pairs, and their respective
product sizes used in this study are as follows: trcR1, SH36 and SH45 (5⬘-CCA
GGATGGCTTGCCGCGGACGTTGACTGC-3⬘), 352 bp; trcR2, SH35 (5⬘-GA
TGACGGGATTGTGCTGGA-3⬘) and SH58 (5⬘-CAGGTCCGGGTGCCTTC
GAG-3⬘), 359 bp; trcR3, SH36 and SH51 (5⬘-GTCGTCATGCTCCCGTATCC3⬘), 305 bp; trcR4, SH36 and SH56 (5⬘-GAAAGCGGATCTCGGTTTCC-3⬘),
163 bp; trcR5, SH57 (5⬘-ACAACCTGGTCACGATCAGC-3⬘) and SH53 (5⬘-T
TCGGCCTGAAAAGGTGACC-3⬘), 129 bp; trcR6, SH55 (5⬘-CACCGCCGAA
GCCCGACATC-3⬘) and SH51, 141 bp; trcR7, SH55 and SH52 (5⬘-ATGCAGT
TGTCACGGGATTC-3⬘), 98 bp; trcR8, SH55 and SH53, 46 bp; trcR9, SH54
(5⬘-AGGCCGAAGTAACTACATAAG-3⬘) and SH51, 103 bp; trcR10, SH54
and SH61 (5⬘-CAAGCGCACATGCAGTTGTC-3⬘), 69 bp; trcR11, SH54 and
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SH52, 60 bp. PCR products were electrophoresed through agarose gels, and
amplified bands were removed from the gels and purified by using the Elu-Quik
kit (Schleicher & Schuell). Purified PCR products were quantitated by using
GeneQuant (Amersham Pharmacia Biotech), and approximately 100 to 150 ng
of each product was end labeled with DIG-11-ddUTP. Primers SH63 (5⬘-ATA
AGCGACATTTGAAAAATTTATGAAT-3⬘) and SH64 (5⬘-ATTCATAAATT
TTTCAAATGTCGCTTAT-3⬘) were synthesized and 3⬘ end labeled with DIG
by IDT, Inc. The SH63 and SH64 complementary primers were heated to 95°C
for 10 min in TEN buffer (10 mM Tris [pH 8.0], 1 mM EDTA, 100 mM NaCl)
and allowed to anneal slowly by gradual cooling at room temperature to create
fragment trcR12. Binding reaction mixtures contained 1 g of TrcR protein and
approximately 1 to 10 ng of DIG-labeled promoter PCR fragments. Binding
reactions were performed as described in the manufacturer’s protocol (Roche) in
binding reaction buffer [20 mM HEPES (pH 7.6), 1 mM EDTA, 10 mM
(NH4)2SO4, 1 mM DTT, 0.2% (wt/vol) Tween 20, 30 mM KCl] and were supplemented with poly(dI-dC), poly(dA-dT), and 50 mM acetyl phosphate, when
appropriate. Incubations were carried out for 30 min at room temperature, and
the reaction mixtures were loaded onto 8% nondenaturing polyacrylamide gels
containing 0.25⫻ Tris-borate-EDTA. Electrophoresis was performed at 4°C at
80 to 100 V for 1.5 to 2 h. The DNA-protein complexes were then electroblotted
onto a positively charged Hybond-N⫹ nylon membrane (Amersham Pharmacia
Biotech) and detected by anti-DIG-alkaline phosphatase and the CSPD chemiluminescent alkaline phosphatase substrate as described by the manufacturer
(Roche). Membranes were exposed to X-ray film at room temperature for 15 to
60 min.
DNase I footprinting of the trcR promoter. A 364-bp DNA fragment comprising the trcR promoter region was PCR amplified by using forward primer SH57
and reverse primer SH27 (5⬘-CCATCTTGACCAGATTGGTCA-3⬘). For generating single, end-labeled probes, either SH57 or SH27 was end labeled with T4
polynucleotide kinase (Epicentre Technologies, Madison, Wis.) and [␥-32P]ATP
(specific activity, ⬎7,000 Ci/mmol; NEN Life Science) and used in a PCR with
plasmid pYH4 (9) serving as a template. Radioactive trcR probes were purified
by using QIAquick spin columns (Qiagen Inc.) and quantitated with a Wallac
1410 scintillation counter (Amersham Pharmacia Biotech). Binding reaction
mixtures in a total volume of 50 l consisted of approximately 50,000 cpm of
labeled DNA probe and various concentrations of TrcR in binding buffer (50
mM Tris-HCl [pH 7.6], 50 mM KCl, 10 mM MgCl2, 1 mM CaCl2, 1 mM DTT,
0.1 mM EDTA) containing 100 ng of poly(dI-dC) as a nonspecific competitor.
After a 30-min incubation at room temperature, binding reactions were subjected to DNase I digestion for 1 min and then terminated by the addition of 100
l of stop buffer (20 mM EDTA, 1% sodium dodecyl sulfate, 200 mM NaCl, 125
g of Saccharomyces cerevisiae tRNA per ml). Phosphorylated TrcR (TrcR⬃P)
was generated by preincubating TrcR with 50 mM acetyl phosphate (final concentration) in binding buffer for 30 min at room temperature before addition to
the binding reaction. Samples were extracted once with phenol-chloroform, and
nucleic acids were precipitated with ethanol. The DNA was resuspended in
formamide dye and separated on a 6% polyacrylamide sequencing gel.
Dideoxynucleotide sequencing reactions were performed using the SequiTherm
EXCEL II DNA Sequencing Kit (Epicentre Technologies) with the same endlabeled primer as the one used in the footprinting reaction, and the products
were electrophoresed in parallel with the TrcR footprinting reactions.
Construction of a trcR promoter mutant. The trcR promoter mutant in which
36 bp of the wild-type trcR promoter AT-rich sequence was replaced with a
random 36-bp sequence was constructed by using various other trcR promoter
plasmids. Plasmid pSH234 consists of a 94-bp distal portion of the trcR promoter
and 116 bp of the upstream flanking DNA amplified with primers SH36 and
SH53 and cloned into the pGEM-T vector. Plasmid pSH237 consists of a 51-bp
proximal portion of the trcR promoter and 144 bp of the trcR coding sequence
amplified with primers SH75 (5⬘-CCCGTGACAACTGCATGTGC-3⬘) and
RHtrcR1 (5⬘-CTTGACCAGATTGGTCAGCGCTGG-3⬘) and cloned into
pGEM-T. Plasmid pSH234 was digested with PstI and EagI and treated with
Klenow DNA polymerase to obtain a partially blunt-end fragment containing the
distal trcR promoter and 21 bp of the pGEM-T vector. This blunt-end fragment
was then ligated to NcoI-restricted and blunt-ended pSH237 plasmid. A portion
of the ligation reaction mixture was used as a template for PCR using primers
SH36 and RHtrcR1. The amplified DNA which replaces the original trcR 36-bp
AT-rich sequence with 36 bp of sequence from the pGEM-T vector was then
digested with PshAI and RsaI for ligation into the ScaI-digested pSEH100. The
resulting plasmid, pSH266, was cotransformed with pSH33 into E. coli JM109
and selected on LB/Ap/Km plates. Cultures were grown and ␤-galactosidase
assays were performed as described above with the pSH93 plasmid containing
the wild-type trcR promoter sequence.
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FIG. 1. RT-PCR analysis of trcR and trcS from M. tuberculosis. (A) Schematic diagram of the M. tuberculosis trcR and trcS genes and the
gene-specific primers used in the RT-PCRs. The direction of transcription for trcR and trcS is represented by arrows. PCR primers are indicated
by single-headed arrows. Numbers within parentheses below each indicated PCR product refer to the PCR primer sets. (B) Total M. tuberculosis
RNA (1 to 2 g) from two different isolates (H37Rv [odd-numbered lanes] and TB233 [even-numbered lanes]) was reverse transcribed and
amplified with the trcR- and/or trcS-specific primers indicated in panel A. The numbers below each set of lanes refer to the primer pairs depicted
in panel A. Lanes: 1 and 2, RT-PCR of trcR coding region; 3 and 4, RT-PCR of trcR-trcS intergenic region; 5 and 6, RT-PCR of trcS coding region;
7 to 10, control PCR amplifications without RT using primer sets 1 and 3, respectively, of the same RNA samples used in the RT-PCRs.

RESULTS
trcR and trcS transcription. The trcR and trcS genes are
adjacent to one another on the M. tuberculosis chromosome,
with the response regulator located upstream of the sensor
(Fig. 1A). The nucleotide sequence upstream of the apparent
translation initiation codon of trcS is separated from the stop
codon of trcR by 7 bp. To determine if trcR and trcS are
transcribed in the M. tuberculosis H37Rv strain and a clinical
isolate strain (TB233), RT-PCR was performed. Primer annealing sites within the coding regions of trcR and trcS and the
respective PCR products are depicted in Fig. 1A. The RT-PCR
products shown in Fig. 1B indicate that trcR (lanes 1 and 2),
trcS (lanes 5 and 6), and the intergenic region between trcR and
trcS (lanes 3 and 4) are transcribed. To verify that these RNA
samples were not contaminated with genomic DNA, PCRs
were performed without the RT step. The lack of amplification
products for trcR or trcS (Fig. 1B, lanes 7 to 10) verifies that the
RT-PCR products were amplified from RNA that had been
reverse transcribed into cDNA. These results indicate that
trcR, trcS, and the intergenic region between trcR and trcS are
transcribed in both M. tuberculosis H37Rv and a virulent clinical isolate, TB233, and that the two genes are possibly cotranscribed as an operon.
Analysis of trcR and trcS gene expression in broth-grown

M. tuberculosis cultures and macrophage-infected bacilli. The
SCOTS procedure is a technique that can be used to evaluate
microbial gene expression in a given environment (8). This
technique allows for the capture of cDNAs corresponding to
mRNAs that are present in a specific culture condition. The
captured cDNAs are hybridized with biotinylated genomic
DNA, amplified by PCR, labeled, and used as probes for
Southern blot hybridizations. Previously, SCOTS cDNA
probes were generated from broth-grown M. tuberculosis and
from M. tuberculosis recovered at specific times after infection
of macrophages (8). Considering that the above RT-PCR experiments demonstrated that trcR and trcS were transcribed in
broth-grown cultures, SCOTS (8) analysis was performed to
verify the above results and to determine if trcR was also
expressed when M. tuberculosis was growing within macrophages. Figure 2 shows the Southern blot analysis of the trcR
and trcS genes using various SCOTS cDNA probes from M.
tuberculosis grown in laboratory media and in macrophages.
The trcR and trcS genes hybridized with the SCOTS probes
generated from early-logarithmic-phase cultures and mid-logarithmic-phase cultures (Fig. 2, lanes 2, 3, 6, and 7). While
hybridization is evident with both early-logarithmic- and midlogarithmic-phase cultures, the regulatory genes are preferentially expressed during early logarithmic growth (Fig. 2, lanes 2
and 3). To determine if these genes were also expressed during
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FIG. 2. SCOTS analysis of trcR and trcS expression. M. tuberculosis SCOTS cDNA probes (8) from early-logarithmic-phase broth-grown
cultures, mid-logarithmic-phase broth-grown cultures, 18-h growth in macrophages, and 48-h growth in macrophages were used in Southern blot
analysis of the trcR and trcS genes. Plasmid pYH4 was digested with appropriate restriction enzymes to separate the trcR and trcS genes from the
remaining vector sequences (lanes 2 and 3, 6 and 7, 10 and 11, and 14 and 15). The detected trcR and trcS DNA fragments are indicated with
asterisks, while the trcR and trcS flanking DNA sequences present on pYH4 and detected by the probes remain unmarked. Plasmid pSH337
harboring the partial open reading frame of clpC was also digested with restriction enzymes to release the clpC fragment and used as a positive
hybridization control (lanes 1, 5, 9, and 13). Marker, 1-kb DNA ladder (lanes 4, 8, 12, and 16).

M. tuberculosis intracellular growth, Southern analysis was
performed using SCOTS cDNA probes developed after 18
and 48 h of M. tuberculosis growth in macrophages. Hybridization of the SCOTS probe from 18 h of growth in macrophages indicates that trcR and trcS are expressed after initial
macrophage infection (Fig. 2, lanes 10 and 11). However, the
trcR and trcS genes did not hybridize with SCOTS probes
developed after 48 h of growth in macrophages (Fig. 2, lanes 14
and 15) or after 110 h of growth in macrophages (data not
shown), indicating that these genes are not expressed after
longer periods of macrophage infection. The M. tuberculosis
clpC (Rv3596c) gene (partial open reading frame) was previously determined to hybridize with SCOTS probes developed
after growth in liquid media and after 18 and 48 h of growth in
macrophages (S. E. Haydel and J. E. Clark-Curtiss, unpublished data) and was used as a hybridization control (Fig. 2,
lanes 1, 5, 9, and 13).
Western blot analysis of TrcR in M. tuberculosis cultures.
Since RT-PCR and SCOTS analyses established that the trcR
and trcS genes are transcribed in broth-grown cultures, M.
tuberculosis protein extracts were analyzed by Western blotting
using TrcR polyclonal antiserum generated in rabbits. As
shown in Fig. 3, TrcR expression was detected during logarithmic growth of M. tuberculosis. These results correlate TrcR
protein expression with the trcR RNA data obtained from the
aforementioned RT-PCR experiments (Fig. 1B) and trcR
SCOTS analysis (Fig. 2). In nondenaturing polyacrylamide
gels, purified TrcR migrated as two forms believed to be its
monomeric and dimeric forms (Fig. 3, lane 4). In the early- and
mid-logarithmic M. tuberculosis protein samples (Fig. 3, lanes 1
and 2), TrcR sera reacted with protein bands that correlate in
size with purified TrcR (Fig. 3, lane 4). However, in the latelogarithmic M. tuberculosis protein sample, TrcR sera reacted
primarily with a protein antigen corresponding with the larger
form of TrcR (Fig. 3, lane 3). These results indicate that the
TrcR protein is expressed during logarithmic growth and sug-

gest that TrcR exists in more than one form during logarithmic
growth.
TrcR autoregulation. To investigate whether trcR is subject
to transcriptional autoregulation, transcriptional fusions were
constructed between the trcR promoter and a promoterless
lacZ gene. The trcR promoter was fused to the lacZ gene
within pSEH100 (described in Materials and Methods), a modified pJEM15 E. coli-mycobacterial shuttle vector (31), to create plasmid pSH93. The pSH33 plasmid with an inducible
TrcR protein (9) and pSH93 were cotransformed into E. coli,
and ␤-galactosidase activity was measured to assess the levels
of trcR transcription with and without induction of the TrcR
response regulator. As shown in Fig. 4, in E. coli cells harboring the trcR-lacZ fusion clone and the IPTG-induced TrcR
clone, a steady and significant increase in promoter activity was

FIG. 3. Western blot analysis of TrcR expression in M. tuberculosis.
Whole-cell protein extracts from M. tuberculosis H37Rv were separated by native PAGE and subjected to immunoblot analysis with TrcR
polyclonal antiserum. Lanes 1 to 3 represent M. tuberculosis protein
samples extracted from cultures grown to optical densities at 600 nm of
0.25, 0.48, and 0.70, respectively. Lane 4 represents purified His-tagged
TrcR protein (0.10 g). As a control, lane 5 contains an E. coli protein
extract of strain JM109 expressing the dihydrofolate reductase protein
from the pQE40 expression vector. Size standards are indicated in
kilodaltons.
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FIG. 4. Regulation of the trcR-lacZ transcriptional fusion in the presence of TrcR. Expression of the trcR-lacZ transcriptional fusion in the
presence of inducible TrcR. Columns: 1, trcR-lacZ plasmid (pSH93); 2, trcR-lacZ plasmid (pSH93) and uninduced TrcR (pSH33); 3 to 6, trcR-lacZ
plasmid (pSH93) and TrcR (pSH33) induced with IPTG for 15, 30, 45, and 60 min, respectively; 7, uninduced TrcR (pSH33); 8, induced TrcR
(pSH33). ␤-Galactosidase activities are expressed as Miller units. Results are the averages (indicated above each column) and standard errors from
at least three independent experiments.

evident after 15 to 60 min of TrcR induction as indicated by
elevated levels of ␤-galactosidase (columns 3 to 6). After 60
min of TrcR induction, trcR promoter-driven ␤-galactosidase
expression had increased ⬎500-fold compared to cells incubated under identical conditions but without the TrcR expression plasmid. Even in the presence of low levels of TrcR
protein (uninduced cells), there was a ⬎20-fold increase in
␤-galactosidase production from the trcR promoter (Fig. 4,
column 2). These experiments demonstrate that the TrcR protein is able to transcriptionally activate expression of the trcR
promoter in E. coli.
Gel shift analyses of the trcR promoter. To show that TrcR
was regulating trcR expression by directly binding the trcR
promoter, DNA gel mobility shift assays were performed. A

352-bp fragment encompassing the entire trcR intergenic region plus flanking DNA was amplified and end labeled with
DIG. When recombinant TrcR was incubated with this 352-bp
labeled fragment, trcR1, a marked DNA retardation was evident by a complete shift of the labeled DNA (Fig. 5, lane 2). To
determine if in vitro phosphorylation of TrcR would alter the
binding affinity, TrcR was treated with acetyl phosphate as
described in Materials and Methods. TrcR was phosphorylated
in vitro via the method of McCleary (15) and was expected to
be phosphorylated on the conserved aspartate residue. Since
unphosphorylated TrcR efficiently binds the trcR promoter,
only a decrease in binding would be detected with phosphorylated TrcR. As shown in Fig. 5 (lane 3), phosphorylated TrcR
(TrcR⬃P) did not deter DNA retardation of the trcR pro-

FIG. 5. Gel shift mobility analysis of TrcR binding to the trcR promoter. The full-length trcR promoter is represented by the 352-bp
DIG-labeled trcR1 DNA fragment. The trcR1 promoter fragment is shown unbound (DNA only, lane 1), with TrcR (lane 2), with TrcR⬃P (lane
3), and with TrcRN-term (lane 4). Lane 5 represents specific competition of the labeled trcR1-TrcR complex with 50-fold excess of unlabeled trcR1.
Lanes 6 and 7 represent nonspecific competitions of the labeled trcR1-TrcR complex with 125-fold excess of poly(dI-dC) and 50-fold excess of M.
tuberculosis DNA fragment trcR2, respectively. Protein-DNA complexes were separated in 8% native polyacrylamide gels and analyzed by
autoradiography. Each reaction mixture contained 1 g (approximately 1.6 M) of TrcR or TrcRN-term.
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moter. (It should be noted that titrations of TrcR and TrcR⬃P
are performed in the footprinting experiments discussed below
to more precisely determine the effect of TrcR phosphorylation.) However, when only the N-terminal portion of the TrcR
protein, which contains the phosphoaccepting domain but
lacks the DNA binding domain, was added to the trcR promoter fragment, the DNA was not shifted (Fig. 5, lane 4).
To test if the TrcR binding reaction was specific, unlabeled
trcR1 DNA was used in a competition assay. As seen in Fig. 5
(lane 5), with a 50-fold excess of unlabeled trcR1 as a specific
DNA competitor, the binding of TrcR is lost. Since the genome of M. tuberculosis is 65% G⫹C, a competition assay with
a 125-fold excess of nonspecific poly(dI-dC) DNA was performed. In assays with poly(dI-dC) DNA (Fig. 5, lane 6) or a
50-fold excess of M. tuberculosis nonspecific DNA competitor,
trcR2 (a 359-bp fragment located 240 bp upstream of the trcR
coding region) (Fig. 5, lane 7), specific binding activity of TrcR
to the trcR1 fragment was retained. These results indicate that
TrcR is binding to the trcR promoter region in a sequencespecific manner.
The trcR promoter region important for TrcR binding. Once
it was determined that TrcR was binding directly to the trcR
promoter, a more precise characterization of the trcR promoter
region important for binding was addressed. To delineate the
minimal trcR promoter sequence essential for TrcR binding, various overlapping fragments of the trcR promoter were generated.
The trcR promoter regions analyzed are shown schematically in
Fig. 6A. As shown in Fig. 6B, a series of gel mobility shift assays
were performed with these delimited trcR promoter fragments
and 1 g of unphosphorylated TrcR. As expected, a full-length
trcR promoter fragment, trcR3, was shifted in the presence of
TrcR (Fig. 6B, lane 2). However, fragments containing the distal
upstream regions of the trcR promoter, trcR4 and trcR5, were not
shifted upon incubation with TrcR (Fig. 6B, lanes 4 and 6, respectively). Thus, TrcR is apparently binding to a promoter region within 86 bp of the trcR translational start site. Incubation of
TrcR with proximal trcR promoter fragments, trcR6 and trcR7,
induced complete gel shifts of both fragments (Fig. 6B, lane 8,
and data not shown). To further define the TrcR-binding region,
five additional and shorter fragments were analyzed. Fragments
trcR9, trcR10, and trcR11 were all gel shifted by TrcR (Fig. 6B,
lane 12, and data not shown). However, TrcR incubation with
fragment trcR8 did not induce a gel shift (Fig. 6B, lane 10). In an
attempt to determine a core sequence important for binding, two
complementary 28-mer DIG-labeled oligonucleotides, SH63 and
SH64, were annealed to create the trcR12 fragment and incubated in gel shift reaction mixtures with TrcR. As shown in
Fig. 6B, lane 14, the trcR12 fragment was shifted in the presence of TrcR. Comparing the trcR promoter regions that
were bound by TrcR and determining that the smallest fragment was completely shifted by TrcR (trcR12) indicate that
TrcR is binding to the trcR promoter within a 28-bp region
(Fig. 6C).
Sequence analysis of the trcR promoter within a 69-bp region
(trcR10) revealed the presence of a 38-bp stretch of DNA that
is extremely AT rich (29 of 38, or 76%). The 28-bp trcR12
fragment lies within this 38-bp region and exhibits 78% A⫹T
content (Fig. 6C). It should be noted that this high A⫹T
content is in striking contrast with the 35% A⫹T content of the
M. tuberculosis genome. These delimiting gel shift assays dem-
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onstrate that the TrcR protein interacts with the AT-rich region of the trcR promoter.
DNase I protection of the trcR promoter by TrcR. Although
gel mobility shift assays revealed that TrcR was interacting
with the AT-rich region of the trcR promoter, DNase I protection analyses were also performed on both strands to analyze the effects of TrcR phosphorylation on DNA binding
activity (Fig. 7). Using a 364-bp trcR promoter fragment carrying the AT-rich sequence, unphosphorylated TrcR protected
58 bp (from positions ⫺21 to ⫺78 in relation to the translational start site) of the trcR noncoding strand (Fig. 7A) and 72
bp (from ⫺4 to ⫺75) of the trcR coding strand (Fig. 7C). Upon
incubation with in vitro-phosphorylated TrcR (TrcR⬃P), the
TrcR binding site was increased to 68 bp (from ⫺11 to ⫺78)
for the trcR noncoding strand (Fig. 7B) and to 86 bp (⫺4 to
⫺89) for the trcR coding strand (Fig. 7D). With an excess of
TrcR (6.5 M), a marked region of DNase I hypersensitivity
was introduced into the footprint of the trcR noncoding strand
(Fig. 7A). However, with 10-fold-less protein, TrcR⬃P induced a DNase I hypersensitivity site at a slightly different
location (Fig. 7B). Protected regions of the trcR coding strand
with TrcR and TrcR⬃P were similar in that both exhibited the
same site of DNase I hypersensitivity; however, TrcR⬃P produced a footprint of 86 bp, which was larger than the TrcR
footprint of 72 bp (Fig. 7C and D).
The protected region of the trcR promoter includes the
majority of the 28-bp AT-rich sequence deemed important in
TrcR binding in gel mobility shift assays (Fig. 8). For the trcR
noncoding strand, the TrcR and TrcR⬃P nuclease-protected
region included 27 of the 28 bp of the AT-rich sequence. For
the trcR coding strand, TrcR protected 24 bp of the 28-bp
sequence, and TrcR⬃P protection encompassed the complete
28-bp AT-rich sequence. The protected regions also extended
an additional 31 to 48 bp downstream of this AT-rich region
(Fig. 8). Both TrcR and TrcR⬃P induced DNase I hypersensitivity sites within the AT-rich region of the trcR noncoding
strand (Fig. 8); however, the TrcR⬃P hypersensitivity site is
evident at a lower protein concentration (Fig. 7B). These data
confirm the results of gel shift studies and indicate that TrcR
interacts with the AT-rich region of the trcR promoter.
Analysis of a trcR promoter mutant in autoregulation experiments. Since previous experiments indicated that TrcR
could regulate its own synthesis and bind to the AT-rich sequence within its promoter region, the trcR promoter was mutated in order to determine if the AT-rich sequence was also
involved in modulating TrcR autoregulation. A 36-bp region of
the trcR promoter which contains the AT-rich sequence was
replaced with a nonspecific 36-bp DNA fragment (Fig. 9A).
Other than the replacement of the 36-bp stretch of AT-rich
sequence, the mutated trcR promoter-lacZ fusion plasmid,
pSH266, is identical to the pSH93 plasmid used in the autoregulation studies. The mutated trcR-lacZ fusion plasmid was
subjected to experiments identical to the aforementioned TrcR
autoregulation experiments (shown in Fig. 4). As shown in Fig.
9B, in comparing E. coli cells harboring the mutated trcR-lacZ
fusion clone alone (column 1) and cells harboring both the
mutated trcR-lacZ fusion clone and the IPTG-induced TrcR
clone (columns 2 to 4), there are no significant changes in
␤-galactosidase activity produced from the trcR promoter. It
should also be noted that ␤-galactosidase production levels

VOL. 184, 2002

MYCOBACTERIUM TUBERCULOSIS TrcR CHARACTERIZATION

2199

FIG. 6. Schematic representation of the M. tuberculosis IS1560-trcR intergenic region and trcR promoter-TrcR binding specificity. (A) DIGlabeled PCR fragments (trcR1 and trcR3 to trcR11) were used to generate overlapping trcR promoter DNA fragments for TrcR gel mobility shift
assays. Fragment trcR12 was created by annealing two DIG-labeled complementary 28-mer primers. The trcR fragment numbering reflects the trcR
start codon as ⫹1. Hatched boxes represent PCR fragments that were shifted by TrcR. Open boxes indicate PCR fragments that were not shifted
in the presence of TrcR. PCR primers are described in Materials and Methods. (B) Mapping of the TrcR binding site within the trcR promoter
using a series of delimiting and overlapping DNA fragments. Fragments encompassing the distal promoter sequences are shown in lanes 3 to 6
and lanes 9 and 10. Proximal promoter regions are shown in lanes 7 and 8 and lanes 11 to 14. All protein-DNA binding reactions (even-numbered
lanes) were performed with 1 g (approximately 1.6 M) of TrcR. (C) Location of the trcR promoter region important for TrcR binding. The
AT-rich sequence is shown in bold type, and the 28-bp sequence bound by TrcR is boxed. PCR primers are indicated by single-headed arrows above
and below the sequence.

from the wild-type trcR promoter (Fig. 4, lane 1) and from the
mutated trcR promoter (Fig. 9B, lane 1) are similar. However,
␤-galactosidase activity levels driven from the mutated trcR
promoter remain unchanged regardless of whether or not

TrcR was induced (Fig. 9B, lanes 2 to 4). These results signify
that not only does TrcR bind to the AT-rich sequence, but this
sequence is also essential in promoting TrcR regulation of trcR
transcription.
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FIG. 7. DNase I footprinting analysis of the trcR promoter with TrcR and TrcR⬃P. Binding reaction mixtures containing the trcR promoter
noncoding upper strand (A and B) or coding lower strand (C and D) were subjected to nuclease treatment in the absence of TrcR (⫺) or with
increasing amounts of TrcR (lanes 2 to 7). The concentration of TrcR or TrcR⬃P present in each reaction mixture is as follows: lane 2, 0.006 M;
lane 3, 0.065 M; lane 4, 0.325 M; lane 5, 0.650 M; lane 6, 3.25 M; lane 7, 6.50 M. The protected trcR region is indicated with a notched
vertical bar. The single and double asterisks indicate a region of DNase I hypersensitivity for TrcR and TrcR⬃P, respectively.
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FIG. 8. Footprinting sequence of the trcR promoter region. The protected regions for TrcR (solid bracket) and TrcR⬃P (dashed bracket) are
indicated for both strands. The TrcR and TrcR⬃P hypersensitivity sites are indicated by single and double asterisks, respectively. The sequence
numbering is relative to the trcR translational start site.

DISCUSSION
Two-component system response regulators have been
shown to control numerous types of adaptive responses and
modulate the expression of genes or activities of many different
proteins under a variety of environmental conditions. These
regulators can act as DNA binding proteins to activate or
repress transcriptional activity of the targeted genes. While it
had previously been shown that the M. tuberculosis TrcS and
TrcR proteins function as signal-transducing proteins capable
of cognate phosphorylation communication (9), the regulated
genes of this two-component system had not been identified.
The goals of the experiments in this report were to determine
if the trcRS genes are expressed in broth-grown cultures and/or
in macrophages, to begin identifying the regulated genes of the
M. tuberculosis TrcR response regulator, and to biochemically
characterize the TrcR binding site.
Based on homology, the TrcR response regulator can be
grouped with the OmpR subfamily of response regulators that
exhibit carboxy terminus helix-turn-helix DNA binding motifs
(22). A number of two-component system genes from this
group of response regulators have previously been shown to be
autoregulated. The PhoPQ system from S. enterica serovar
Typhimurium, the BvgAS system from B. pertussis, and the
VanRS system from Enterococcus faecium are all important in
regulating virulence pathways and are also involved in autoregulation (12, 27, 29). For Mycobacterium smegmatis, autoregulatory experiments with the regX3 promoter indicate that
there is a twofold increase in transcriptional activity when the
regX3 and senX3 genes are provided (11). In autoregulation
experiments presented here, the TrcR response regulator activates trcR transcription more than 500-fold. Since this substantial activation occurs in E. coli without the TrcS histidine
kinase, it is likely that TrcR can regulate its own expression
independent of phosphorylation. However, it is currently unknown if TrcR is subjected to low levels of phosphorylation via
cross talk with another native E. coli histidine kinase or by a
small-molecule phosphodonor, such as acetyl phosphate.
The initial establishment of trcR autoregulation led to the
question of how TrcR was activating transcription. In gel mobility shift assays, we have demonstrated that the TrcR response regulator binds to a 28-bp fragment of the trcR promoter. The gel shifts demonstrated with TrcR have also been
evident with other two-component response regulators, OmpR

(21), ComA (24), BvgA (13, 25), VanR (12), ToxR (10), and
their target promoters, and could be the result of oligomerization during DNA binding and/or DNA bending.
Several response regulators in their unphosphorylated state
are able to bind DNA. Unphosphorylated BvgA from B. pertussis can efficiently bind to both the fhaB and bvgA promoters
(25). The unphosphorylated VanR response regulator from
E. faecium is also able to bind the vanH and vanR promoters;
however, 10-fold-less-phosphorylated VanR can bind with similar affinity (12). B. subtilis PhoP has been shown to dimerize
and bind to the phoB promoter in both phosphorylated and
unphosphorylated states (14). However, while 1 g of PhoP⬃P
efficiently retarded the phoB promoter, 200 g of unphosphorylated PhoP was required for binding (14). In contrast, only 1
g of TrcR or TrcR⬃P was able to completely retard the trcR
promoter. Response regulator phosphorylation could lead to
oligomeric protein states and cooperative binding that might
not always be important for binding to certain target promoters
(21). The low concentration of TrcR required to induce a
complete shift suggests that the phosphorylation state of TrcR
is not critical in binding the trcR promoter.
In DNase I footprinting analyses, while similar concentrations of TrcR and TrcR⬃P are able to efficiently protect the
trcR promoter, TrcR⬃P exhibits a 10-fold increase in binding
affinity and protects a slightly larger region. This extended
footprint observed with TrcR⬃P may signify an oligomerization of TrcR or a secondary region for binding by TrcR⬃P.
Since sites of DNase I hypersensitivity usually indicate tandem
protein binding sites (1), symmetric binding of TrcR⬃P is
suggested by the presence of a hypersensitivity site with low
concentrations of protein.
Response regulators often bind to consensus sequences that
can be determined by analyzing multiple binding sites. These
consensus binding sites are usually found as inverted repeats,
direct repeats, or as several sites spaced widely throughout the
promoter. In observations of the identified binding sites of
B. pertussis BvgA, S. enterica serovar Typhimurium PhoP, E. faecium VanR, and E. coli OmpR, the consensus target DNA for
each response regulator is AT rich (12, 25, 29, 32). Common to
all of these binding sites is the presence of a TTT sequence
within an AT-rich stretch of DNA. Similar to these response
regulator binding sites, the 28-bp TrcR binding sequence was
also determined to be an AT-rich region that contains two TTT
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FIG. 9. Analysis of the mutated trcR-lacZ fusion in the presence of TrcR. (A) DNA sequence of the wild-type and mutated trcR promoter
sequences. A 36-bp region of the wild-type trcR promoter containing the AT-rich sequence was replaced with a nonspecific 36-bp region to create
the mutated trcR promoter. (B) Expression of the mutated trcR-lacZ transcriptional fusion in the presence of inducible TrcR. Columns: 1, mutated
trcR-lacZ plasmid (pSH266); 2, mutated trcR-lacZ plasmid (pSH266) and uninduced TrcR (pSH33); 3, mutated trcR-lacZ plasmid (pSH266) and
TrcR (pSH33) induced for 30 min; 4, mutated trcR-lacZ plasmid (pSH266) and TrcR (pSH33) induced for 60 min. ␤-Galactosidase activities are
expressed as Miller units. Results are the averages (indicated above each column) and standard errors from at least three independent experiments.

sequences (Fig. 8). Through the use of the available M. tuberculosis genome sequence (3), it was determined that this 28-bp
AT-rich sequence in the exact form does not exist elsewhere in
the genome. However, sequences similar to this 28-bp AT-rich
sequence are present and are currently being investigated as
possible TrcR-targeted sequences (S. E. Haydel and J. E.
Clark-Curtiss, unpublished data). Mutagenesis of the trcR promoter by replacing a 36-bp AT-rich region with nonspecific
DNA demonstrated that this sequence is required for TrcR
autoregulation. While the biochemical studies demonstrated
the importance of the AT-rich region in TrcR binding, the

mutational genetic experiments confirmed that the AT-rich
sequence is essential for TrcR autoregulation.
The development of SCOTS to investigate gene expression
in various environments (8) has proven to be a very useful
laboratory tool. While the initial application identified numerous M. tuberculosis genes that are specifically expressed during
growth in human macrophages (8), the SCOTS cDNA probes
can be used to analyze the expression of any M. tuberculosis
gene under any given (or desired) growth condition. SCOTS
analysis of the trcR and trcS genes revealed that these genes are
expressed in logarithmic-phase broth-grown cultures as well as
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after initial M. tuberculosis infection of human blood monocyte-derived macrophages. Expression of trcR and trcS after
early infection of macrophages, but not after longer periods of
infection indicates that this two-component system may play an
important role in allowing the organism to adapt to an intracellular environment. In addition to a possible role in M. tuberculosis intracellular adaptation, the trcR and trcS genes
could also be expressed when the tubercle bacilli are replicating extracellularly within the liquefied cavity after breakdown
of the walled-off granuloma. Moreover, trcR/trcS expression
could occur at the end of the latency stage or at the initiation
of reactivation. Thus, the TrcR-TrcS regulatory system may act
as a transition regulatory system involved in adapting to an
intracellular environment and transitioning from latency to
reactivation.
The identification of a gene promoter that the M. tuberculosis TrcR response regulator regulates and the biochemical
characterization of its binding interaction are a great advancement in beginning to understand the TrcRS two-component
system. While the trcR promoter represents the first TrcRtargeted and TrcR-activated promoter to be identified, efforts
are currently under way to identify other TrcR-regulated
genes. Elucidation of other promoters targeted by TrcR will
lead to the definition of a consensus TrcR-binding site and the
possibility of identifying other genes regulated by this system.
Identification of the target sites to which TrcR is binding will
allow future studies regarding the regulatory features of the
TrcR response regulator.
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